AGP Executive Report
Last update: 8 hours agoDrug Safety & Public Health: Taiwan reported suspected drug-impaired driving in two fatal crashes—one in Taichung involving ketamine, and another in Taoyuan linked to amphetamine—raising renewed concerns about substance use and road safety. Healthcare Access & Biotech Deals: DKSH signed a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a transthyretin stabilizer for ATTR cardiomyopathy across Australia, Singapore, South Korea, and Taiwan. Taiwan Pharma Expansion: PharmaEssentia (Taiwan) acquired Canadian specialty firm FORUS Therapeutics for US$36.5 million, aiming to strengthen its North American commercial footprint for hematology/oncology products. AI in Healthcare: Nvidia is teaming with Abridge to develop a healthcare-focused AI model for clinical conversations, intended for use within Abridge’s platform to support documentation and decision support. Workforce & Care Demand: ManpowerGroup Taiwan said employers expect Q3 hiring to stay positive, led by demand for AI talent and financial-sector consolidation. Clinical Research (FAP): A case series reviewed outcomes of subtotal colectomy with ileorectal anastomosis and intensive endoscopic surveillance in familial adenomatous polyposis.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/af9c6fb4-2b61-4367-852e-7237ba1d9bc4/north-america-gastrointestinal-endoscopy-devices-market-size-2025-to-2035-usd-billion-.png)
